LLY

762.24

-0.35%↓

JNJ

177.06

+0.28%↑

ABBV

219.97

+1.65%↑

UNH

340.04

-0.16%↓

AZN

77.55

-0.35%↓

LLY

762.24

-0.35%↓

JNJ

177.06

+0.28%↑

ABBV

219.97

+1.65%↑

UNH

340.04

-0.16%↓

AZN

77.55

-0.35%↓

LLY

762.24

-0.35%↓

JNJ

177.06

+0.28%↑

ABBV

219.97

+1.65%↑

UNH

340.04

-0.16%↓

AZN

77.55

-0.35%↓

LLY

762.24

-0.35%↓

JNJ

177.06

+0.28%↑

ABBV

219.97

+1.65%↑

UNH

340.04

-0.16%↓

AZN

77.55

-0.35%↓

LLY

762.24

-0.35%↓

JNJ

177.06

+0.28%↑

ABBV

219.97

+1.65%↑

UNH

340.04

-0.16%↓

AZN

77.55

-0.35%↓

Search

iRhythm Technologies Inc

Atvērts

SektorsVeselības aprūpe

171.67 -1.33

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

171.11

Max

174.96

Galvenie mērījumi

By Trading Economics

Ienākumi

16M

-14M

Pārdošana

28M

187M

EPS

-0.95

Peļņas marža

-7.616

Darbinieki

2,000

EBITDA

27M

-5.4M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+4.81% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 29. okt.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

1.6B

6B

Iepriekšējā atvēršanas cena

173

Iepriekšējā slēgšanas cena

171.67

Ziņu noskaņojums

By Acuity

50%

50%

185 / 371 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bullish Evidence

iRhythm Technologies Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 16. sept. 17:03 UTC

Galvenie tirgus virzītāji

BrainsWay Shares Rise on FDA Clearance of Major Depressive Disorder Treatment

2025. g. 16. sept. 16:49 UTC

Galvenie tirgus virzītāji
Iegādes, apvienošanās, pārņemšana

GD Culture Shares Drop After Deal for Pallas Capital

2025. g. 16. sept. 16:11 UTC

Galvenie tirgus virzītāji

Corbus Shares Rise on FDA Fast-Track Designation for Cancer Drug

2025. g. 16. sept. 23:40 UTC

Tirgus saruna

Nikkei May Decline as Yen Strengthens -- Market Talk

2025. g. 16. sept. 23:34 UTC

Tirgus saruna

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

2025. g. 16. sept. 23:20 UTC

Tirgus saruna

Restaurant Brands NZ Can Outperform When Cycle Turns -- Market Talk

2025. g. 16. sept. 21:10 UTC

Iegādes, apvienošanās, pārņemšana

U.S. Investors, Trump Close In on TikTok Deal With China -- WSJ

2025. g. 16. sept. 20:51 UTC

Tirgus saruna

U.S. Home Sales, New Home Listings Fall in August -- Market Talk

2025. g. 16. sept. 20:50 UTC

Tirgus saruna

Energy & Utilities Roundup: Market Talk

2025. g. 16. sept. 20:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Basic Materials Roundup: Market Talk

2025. g. 16. sept. 20:25 UTC

Peļņas

The AI Trade Has Stocks Near Highs Again. Some Tech Names Remain on the Sidelines -- Barrons.com

2025. g. 16. sept. 20:24 UTC

Peļņas

These Stocks Moved the Most Today: Oracle, Tesla, Alphabet, Dave & Buster's, Chipotle, and More -- Barrons.com

2025. g. 16. sept. 19:19 UTC

Tirgus saruna

U.S. Natural Gas Futures Extend Winning Streak -- Market Talk

2025. g. 16. sept. 18:52 UTC

Tirgus saruna

Oil Futures Advance on Russia Concerns, Weak Dollar -- Market Talk

2025. g. 16. sept. 18:44 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 16. sept. 18:44 UTC

Tirgus saruna

EssilorLuxottica Well-Positioned in Growing Smart-Glasses Market -- Market Talk

2025. g. 16. sept. 18:40 UTC

Iegādes, apvienošanās, pārņemšana

Details Emerge on U.S.-China TikTok Deal -- WSJ

2025. g. 16. sept. 18:38 UTC

Tirgus saruna

Meta Seen With Long-Term Opportunity to Lead in Smart Glasses -- Market Talk

2025. g. 16. sept. 18:19 UTC

Tirgus saruna

Gold Settles at New High Ahead of Fed Decision -- Market Talk

2025. g. 16. sept. 18:01 UTC

Tirgus saruna

U.S. Dollar Weakness Supports Oil's Gains -- Market Talk

2025. g. 16. sept. 17:34 UTC

Tirgus saruna

Any Question the Bank of Canada Will Cut Now Look to Have Vanished -- Market Talk

2025. g. 16. sept. 16:53 UTC

Peļņas

Software Companies Are Fighting Back With AI. The Stocks Are Still Hurting. -- Barrons.com

2025. g. 16. sept. 16:20 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Basic Materials Roundup: Market Talk

2025. g. 16. sept. 16:15 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Global Commodities Roundup: Market Talk

2025. g. 16. sept. 16:09 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Global Energy Roundup: Market Talk

2025. g. 16. sept. 16:09 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Canada Industry Minister to Meet Mining CEOs on Merger -- Market Talk

2025. g. 16. sept. 15:35 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 16. sept. 15:35 UTC

Tirgus saruna

Gold Soars Past $3,700 Ahead of Fed Decision -- Market Talk

2025. g. 16. sept. 15:22 UTC

Tirgus saruna

More Investors Think Dollar is Overvalued in Latest BofA Survey -- Market Talk

2025. g. 16. sept. 15:21 UTC

Tirgus saruna

Sterling Considered Most Overvalued in Nearly 10 Years -- Market Talk

Salīdzinājums

Cenas izmaiņa

iRhythm Technologies Inc Prognoze

Cenas mērķis

By TipRanks

4.81% augšup

Prognoze 12 mēnešiem

Vidējais 184.64 USD  4.81%

Augstākais 200 USD

Zemākais 170 USD

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi iRhythm Technologies Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

12 ratings

12

Pirkt

0

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

104.78 / 137.91Atbalsts un pretestība

Īstermiņā

Bullish Evidence

Vidējā termiņā

Strong Bullish Evidence

Ilgtermiņā

Bullish Evidence

Noskaņojums

By Acuity

185 / 371 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat